FIUSX
Price
$38.79
Change
+$0.60 (+1.57%)
Updated
Jun 2 closing price
Net Assets
575.91M
JVMRX
Price
$29.43
Change
+$0.26 (+0.89%)
Updated
Jun 2 closing price
Net Assets
22.49B
Interact to see
Advertisement

FIUSX vs JVMRX

Header iconFIUSX vs JVMRX Comparison
Open Charts FIUSX vs JVMRXBanner chart's image
FIUSX vs JVMRX Comparison Chart in %
View a ticker or compare two or three
VS
FIUSX vs. JVMRX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIUSX is a Buy and JVMRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 22.5B vs. FIUSX (576M). JVMRX pays higher dividends than FIUSX: JVMRX (0.81) vs FIUSX (0.57). FIUSX was incepted earlier than JVMRX: FIUSX (34 years) vs JVMRX (15 years). FIUSX (1.20) is less costly to investors than JVMRX (0.75). JVMRX is a more actively managed with annual turnover of: 49.00 vs. FIUSX (18.00). FIUSX has a lower initial minimum investment than JVMRX: FIUSX (1000) vs JVMRX (1000000). FIUSX annual gain was more profitable for investors over the last year : 20.54 vs. JVMRX (7.17). FIUSX return over 5 years is better than : 14.10 vs. JVMRX (5.11).
FIUSXJVMRXFIUSX / JVMRX
Total Expense Ratio1.110.74150%
Annual Report Gross Expense Ratio1.200.75160%
Fund Existence34 years15 years-
Gain YTD16.9686.227272%
Front Load6%N/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets576M22.5B3%
Annual Yield % from dividends0.570.8171%
Returns for 1 year20.547.17287%
Returns for 3 years35.4020.52172%
Returns for 5 years14.105.11276%
Returns for 10 years13.1454.8524%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COP116.871.29
+1.12%
ConocoPhillips
RAND10.730.03
+0.25%
Rand Capital Corp
OMF54.52-0.24
-0.44%
OneMain Holdings
RVLV19.15-0.31
-1.59%
Revolve Group
ELDN3.53-0.23
-6.12%
Eledon Pharmaceuticals